semaglutide phase 1 Efficacy and safety of once-weekly monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre 3a trial Chemical vs. Recombinant: The Manufacturing

Ipamorelina no

We believe that sustainable weight loss should be achieved through science, empathy, and a transparent approach, providing a user-friendly and supportive space where individuals receive personalized, medically supervised care

4 Model of the GLP-1R/GLP-1/LSN3160440/Gs/Nb35 complex in the cryo-EM density map

Nat Prod Res

Clinical trials show semaglutide can cause small increases in resting heart rate, and the Wegovy SmPC lists 'heart rate increased' as an adverse reaction, though individual experiences vary considerably

Quality & Documentation Purity: 99% by HPLC Certificate of Analysis (COA): published on our COA page.